Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers (DELOGAST)

University Hospital, Lille

Status: Active, not recruiting

Conditions: Oesophageal Carcinoma; Gastric Adenocarcinoma

Treatments: Other: Questionnaire

Study type: Interventional

Funder types: Other

Identifiers

NCT03246516

2015_74

2015-A01986-43 (Other Identifier)

Details and patient eligibility

About

This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.

Full description

Reducing the time between the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) is essential to improve the vital prognosis and quality of life of patients. Recent data suggest that some sociocognitive and emotional determinants may explain patient delay from a complementary point of view. The main objective of this study is to assess whether, in oeso-gastric cancer, patient delay is linked to these sociocognitive and emotional factors, in addition to previously known factors.

We intend to include in this study 300 patients with a not yet treated oeso-gastric cancer diagnosed in one of 10 health centres in the North of France region. The collected data will be analysed to underline the differences between patients who consulted a doctor earlier versus those who consulted later with a cut off at 8 weeks.

Enrollment: 258 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age ≥ 18 years
• oesophageal, oeso-gastric junction or gastric cancer non treated cancer
• patient informed of his diagnosis
• speak fluent french

Exclusion criteria

• history of cancer
• psychological history
• patient under guardianship-
• fortuitous diagnosis of cancer

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

258 participants in 1 patient group

Questionnaire

Experimental group

Description:

Auto and hetero questionnaire

Treatment:

Other: Questionnaire